[go: up one dir, main page]

CN101670017B - Medicine combination for tonifying blood - Google Patents

Medicine combination for tonifying blood Download PDF

Info

Publication number
CN101670017B
CN101670017B CN2009103060126A CN200910306012A CN101670017B CN 101670017 B CN101670017 B CN 101670017B CN 2009103060126 A CN2009103060126 A CN 2009103060126A CN 200910306012 A CN200910306012 A CN 200910306012A CN 101670017 B CN101670017 B CN 101670017B
Authority
CN
China
Prior art keywords
extract
pharmaceutical composition
iron
fructus
ferrous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2009103060126A
Other languages
Chinese (zh)
Other versions
CN101670017A (en
Inventor
谢圣明
张廷璧
杨崇琪
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HONGTAOKAI GROUP CORP Ltd
Original Assignee
HONGTAOKAI GROUP CORP Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HONGTAOKAI GROUP CORP Ltd filed Critical HONGTAOKAI GROUP CORP Ltd
Priority to CN2009103060126A priority Critical patent/CN101670017B/en
Publication of CN101670017A publication Critical patent/CN101670017A/en
Application granted granted Critical
Publication of CN101670017B publication Critical patent/CN101670017B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention discloses a medicine combination for tonifying blood and a preparation method thereof, which belongs to the technical field of medicines. The medicine combination comprises the following components: 11.5 to 15.5 g of iron porphyrin extract, 0.05 to 0.09 g of zinc sulfate, 0.7 to 1.3 g of jujube, 0.8 to 1.4 g of Chinese wolfberry, 0.7 to 1.3 g of hawthorn and 1.1 to 1.5 g of sugar. The medicine combination can effectively treat iron-deficiency anemia, and simultaneously has the functions of reinforcing middle, replenishing Qi, tonifying blood, promoting digestion and the like.

Description

A kind of pharmaceutical composition that is used to enrich blood
Technical field
The invention belongs to medical technical field.
Background technology
Iron deficiency anemia is a Deficiency disease common among the crowd, and the haemachrome ferrous porphyrin is the most effective source of iron that supplies of iron deficiency anemia that domestic and international nutritionist is generally acknowledged.Containing a large amount of haemachrome in the animal blood powder, is the effectively nutrient substance of treatment iron deficiency anemia that world nutrition educational circles generally acknowledges, U.S. FDA approved in 1973 becomes to produce and use.Simultaneously, modern science studies have shown that rapid exsiccant tea tree ' s old leaf, silkworm excrement etc. contain a large amount of chlorophylls, extract chlorophyll with them, and ferrous iron is gone in complexation, forms iron pheophytin, and anemia is had significant curative effect.
Hemachrome extract and iron chlorophyll extract combined is prepared into the pharmaceutical composition that is used to enrich blood, and rarely has report in patent and document.
Summary of the invention
The objective of the invention is to address the above problem and a kind of pharmaceutical composition of enriching blood and preparation method thereof is provided.This pharmaceutical composition can effectively be treated iron deficiency anemia, has invigorating middle warmer, QI invigorating simultaneously, rises blood and function such as help digestion.
The technical solution adopted in the present invention is:
A kind of pharmaceutical composition that is used to enrich blood, the component of described pharmaceutical composition is: ferrous porphyrin extract 11.5~15.5g, zinc sulfate 0.05~0.09g, Fructus Jujubae 0.7~1.3g, Fructus Lycii 0.8~1.4g, Fructus Crataegi 0.7~1.3g and sugar 1.1~1.5g.
Preferably, the component of described pharmaceutical composition is: ferrous porphyrin extract 12.8~14.1g, zinc sulfate 0.06~0.08g, Fructus Jujubae 0.8~1.1g, Fructus Lycii 0.9~1.2g, Fructus Crataegi 0.8~1.2g and sugar 1.2~1.4g.
Preferably, the component of described pharmaceutical composition is: ferrous porphyrin extract 13.2~13.9g, zinc sulfate 0.07~0.078g, Fructus Jujubae 0.9~1.0g, Fructus Lycii 1.0~1.1g, Fructus Crataegi 0.9~1.1g and sugar 1.23~1.3g.
The concrete steps of this preparation of pharmaceutical compositions method are:
(1) preparation of ferrous porphyrin extract:
At first, get the animal blood powder, add water and carry out homogenate, boiled 8~15 minutes, cooling back is that 0.1~1% NaOH modulation pH value is 7~9 with mass percent, the hydrolyzed protein enzymatic solution of adding 2000~5000 units, mix homogeneously, hydrolysis under 30~50 ℃ of temperature adds ethanol to precipitation and does not show red, filter, with solution concentration to relative density is 1.05~1.20, adds ethanol once more and removes deproteinize, filters, it is 1.05~1.30 that filtrate is concentrated into relative density, obtains hemachrome extract;
Then, will contain chlorophyllous biomaterial and dry, use the ethanol lixiviate, extract chlorophyll, at 60~95 ℃ of concentrated recovered alcohols, regulating pH value with hydrochloric acid is 3~7, adds ferrous sulfate in 10: 1~10: 5 according to chlorophyll amount and iron ion amount, under boiled condition, generate iron pheophytin, precipitation is separated out, and excessive ferrous sulfate runs off with supernatant, and flushing is precipitated to the iron-free reactant salt repeatedly, carry out drying, obtain iron chlorophyll extract;
Be mixing in 1: 9~4: 6 with above-mentioned hemachrome extract and iron chlorophyll extract according to mass ratio at last, form the ferrous porphyrin extract;
(2) preparation of medicine juice extractum:
After Fructus Lycii, Fructus Jujubae and Fructus Crataegi mixing, decoct with water 1~4 hour, filter, medicinal residues decoct with water 0.5~2 hour again, and the waste extracting juice merges medicine juice, and being concentrated into relative density is 1.05~1.20, obtains medicine juice extractum
(3) preparation of pharmaceutical compositions:
Ferrous porphyrin extract and medicine juice extractum are mixed, add zinc sulfate and sugar, at room temperature dry, promptly obtain this pharmaceutical composition.
The present invention has the following advantages:
Production technology of the present invention is simple, production cost is low; This drug regimen mainly is made up of hemachrome extract and iron pheophytin thing, can effectively treat iron deficiency anemia, has invigorating middle warmer, QI invigorating simultaneously, rises blood and function such as help digestion.
Figure of description
Fig. 1 is the process chart of preparation method of the present invention.
The specific embodiment
Embodiment 1
The pharmaceutical composition that is used to enrich blood, the component of this pharmaceutical composition is: ferrous porphyrin extract 11.5g, zinc sulfate 0.09g, Fructus Jujubae 1.1g, Fructus Lycii 1.0g, Fructus Crataegi 0.9g and sugared 1.1g.
With reference to Fig. 1, the preparation method of this drug regimen is: the preparation of (1) ferrous porphyrin extract: at first, get the animal blood powder, add water and carry out homogenate, boiled 8 minutes, cooling back with mass percent be 1% NaOH to modulate pH value be 8, add the hydrolyzed protein enzymatic solution of 5000 units, mix homogeneously, hydrolysis under 30 ℃ of temperature, adding ethanol to precipitation and do not show red, filter, is 1.10 with solution concentration to relative density, add ethanol once more and remove deproteinize, filter, it is 1.05 that filtrate is concentrated into relative density, obtains hemachrome extract; Then, will contain chlorophyllous biomaterial and dry, use the ethanol lixiviate, extract chlorophyll, at 80 ℃ of concentrated recovered alcohols, regulating pH value with hydrochloric acid is 7, adds ferrous sulfate at 10: 5 according to chlorophyll amount and iron ion amount, under boiled condition, generate iron pheophytin, precipitation is separated out, and excessive ferrous sulfate runs off with supernatant, and flushing is precipitated to the iron-free reactant salt repeatedly, carry out drying, obtain iron chlorophyll extract; Be mixing in 1: 9 with above-mentioned hemachrome extract and iron chlorophyll extract according to mass ratio at last, form the ferrous porphyrin extract; (2) preparation of medicine juice extractum: after Fructus Lycii, Fructus Jujubae and Fructus Crataegi mixing, decoct with water 1 hour, filter, medicinal residues decoct with water 2 hours again, and the waste extracting juice merges medicine juice, and being concentrated into relative density is 1.20, obtains medicine juice extractum; (3) preparation of pharmaceutical compositions: ferrous porphyrin extract and medicine juice extractum are mixed, add zinc sulfate and sugar, at room temperature dry, promptly obtain this pharmaceutical composition.
Embodiment 2
The pharmaceutical composition that is used to enrich blood, the component of this pharmaceutical composition is: ferrous porphyrin extract 12.8g, zinc sulfate 0.078g, Fructus Jujubae 0.7g, Fructus Lycii 1.4g, Fructus Crataegi 0.8g and sugared 1.4g.
With reference to Fig. 1, the preparation method of this drug regimen is: the preparation of (1) ferrous porphyrin extract: at first, get the animal blood powder, add water and carry out homogenate, boiled 15 minutes, cooling back with mass percent be 0.1% NaOH to modulate pH value be 7, add the hydrolyzed protein enzymatic solution of 2000 units, mix homogeneously, hydrolysis under 50 ℃ of temperature, adding ethanol to precipitation and do not show red, filter, is 1.05 with solution concentration to relative density, add ethanol once more and remove deproteinize, filter, it is 1.30 that filtrate is concentrated into relative density, obtains hemachrome extract; Then, will contain chlorophyllous biomaterial and dry, use the ethanol lixiviate, extract chlorophyll, at 60 ℃ of concentrated recovered alcohols, regulating pH value with hydrochloric acid is 3, adds ferrous sulfate at 10: 1 according to chlorophyll amount and iron ion amount, under boiled condition, generate iron pheophytin, precipitation is separated out, and excessive ferrous sulfate runs off with supernatant, and flushing is precipitated to the iron-free reactant salt repeatedly, carry out drying, obtain iron chlorophyll extract; Be mixing in 4: 6 with above-mentioned hemachrome extract and iron chlorophyll extract according to mass ratio at last, form the ferrous porphyrin extract; (2) preparation of medicine juice extractum: after Fructus Lycii, Fructus Jujubae and Fructus Crataegi mixing, decoct with water 4 hours, filter, medicinal residues decoct with water 0.5 hour again, and the waste extracting juice merges medicine juice, and being concentrated into relative density is 1.05, obtains medicine juice extractum; (3) preparation of pharmaceutical compositions: ferrous porphyrin extract and medicine juice extractum are mixed, add zinc sulfate and sugar, at room temperature dry, promptly obtain this pharmaceutical composition.
Embodiment 3
The pharmaceutical composition that is used to enrich blood, the component of this pharmaceutical composition is: ferrous porphyrin extract 13.2g, zinc sulfate 0.05g, Fructus Jujubae 0.8g, Fructus Lycii 0.9g, Fructus Crataegi 1.1g and sugared 1.23g.
With reference to Fig. 1, the preparation method of this drug regimen is: the preparation of (1) ferrous porphyrin extract: at first, get the animal blood powder, add water and carry out homogenate, boiled 12 minutes, cooling back with mass percent be 0.5% NaOH to modulate pH value be 9, add the hydrolyzed protein enzymatic solution of 3500 units, mix homogeneously, hydrolysis under 40 ℃ of temperature, adding ethanol to precipitation and do not show red, filter, is 1.20 with solution concentration to relative density, add ethanol once more and remove deproteinize, filter, it is 1.20 that filtrate is concentrated into relative density, obtains hemachrome extract; Then, will contain chlorophyllous biomaterial and dry, use the ethanol lixiviate, extract chlorophyll, at 95 ℃ of concentrated recovered alcohols, regulating pH value with hydrochloric acid is 5, adds ferrous sulfate at 10: 2 according to chlorophyll amount and iron ion amount, under boiled condition, generate iron pheophytin, precipitation is separated out, and excessive ferrous sulfate runs off with supernatant, and flushing is precipitated to the iron-free reactant salt repeatedly, carry out drying, obtain iron chlorophyll extract; Be mixing in 1: 8 with above-mentioned hemachrome extract and iron chlorophyll extract according to mass ratio at last, form the ferrous porphyrin extract; (2) preparation of medicine juice extractum: after Fructus Lycii, Fructus Jujubae and Fructus Crataegi mixing, decoct with water 2.5 hours, filter, medicinal residues decoct with water 1 hour again, and the waste extracting juice merges medicine juice, and being concentrated into relative density is 1.18, obtains medicine juice extractum; (3) preparation of pharmaceutical compositions: ferrous porphyrin extract and medicine juice extractum are mixed, add zinc sulfate and sugar, at room temperature dry, promptly obtain this pharmaceutical composition.
Embodiment 4
The pharmaceutical composition that is used to enrich blood, the component of this pharmaceutical composition is: ferrous porphyrin extract 15.5g, zinc sulfate 0.06g, Fructus Jujubae 1.0g, Fructus Lycii 1.1g, Fructus Crataegi 0.7g and sugared 1.5g.
With reference to Fig. 1, the preparation method of this drug regimen is: the preparation of (1) ferrous porphyrin extract: at first, get the animal blood powder, add water and carry out homogenate, boiled 8 minutes, cooling back with mass percent be 0.5% NaOH to modulate pH value be 7, add the hydrolyzed protein enzymatic solution of 2000 units, mix homogeneously, hydrolysis under 50 ℃ of temperature, adding ethanol to precipitation and do not show red, filter, is 1.15 with solution concentration to relative density, add ethanol once more and remove deproteinize, filter, it is 1.20 that filtrate is concentrated into relative density, obtains hemachrome extract; Then, will contain chlorophyllous biomaterial and dry, use the ethanol lixiviate, extract chlorophyll, at 60 ℃ of concentrated recovered alcohols, regulating pH value with hydrochloric acid is 7, adds ferrous sulfate at 10: 3 according to chlorophyll amount and iron ion amount, under boiled condition, generate iron pheophytin, precipitation is separated out, and excessive ferrous sulfate runs off with supernatant, and flushing is precipitated to the iron-free reactant salt repeatedly, carry out drying, obtain iron chlorophyll extract; Be mixing in 1: 9 with above-mentioned hemachrome extract and iron chlorophyll extract according to mass ratio at last, form the ferrous porphyrin extract; (2) preparation of medicine juice extractum: after Fructus Lycii, Fructus Jujubae and Fructus Crataegi mixing, decoct with water 4 hours, filter, medicinal residues decoct with water 2 hours again, and the waste extracting juice merges medicine juice, and being concentrated into relative density is 1.20, obtains medicine juice extractum; (3) preparation of pharmaceutical compositions: ferrous porphyrin extract and medicine juice extractum are mixed, add zinc sulfate and sugar, at room temperature dry, promptly obtain this pharmaceutical composition.
Embodiment 5
The pharmaceutical composition that is used to enrich blood, the component of this pharmaceutical composition is: ferrous porphyrin extract 14.1g, zinc sulfate 0.07g, Fructus Jujubae 1.3g, Fructus Lycii 0.8g, Fructus Crataegi 1.3g and sugared 1.2g.
With reference to Fig. 1, the preparation method of this drug regimen is: the preparation of (1) ferrous porphyrin extract: at first, get the animal blood powder, add water and carry out homogenate, boiled 15 minutes, cooling back with mass percent be 0.5% NaOH to modulate pH value be 9, add the hydrolyzed protein enzymatic solution of 5000 units, mix homogeneously, hydrolysis under 50 ℃ of temperature, adding ethanol to precipitation and do not show red, filter, is 1.15 with solution concentration to relative density, add ethanol once more and remove deproteinize, filter, it is 1.30 that filtrate is concentrated into relative density, obtains hemachrome extract; Then, will contain chlorophyllous biomaterial and dry, use the ethanol lixiviate, extract chlorophyll, at 95 ℃ of concentrated recovered alcohols, regulating pH value with hydrochloric acid is 7, adds ferrous sulfate at 10: 5 according to chlorophyll amount and iron ion amount, under boiled condition, generate iron pheophytin, precipitation is separated out, and excessive ferrous sulfate runs off with supernatant, and flushing is precipitated to the iron-free reactant salt repeatedly, carry out drying, obtain iron chlorophyll extract; Be mixing in 4: 6 with above-mentioned hemachrome extract and iron chlorophyll extract according to mass ratio at last, form the ferrous porphyrin extract; (2) preparation of medicine juice extractum: after Fructus Lycii, Fructus Jujubae and Fructus Crataegi mixing, decoct with water 2.5 hours, filter, medicinal residues decoct with water 22 hours again, and the waste extracting juice merges medicine juice, and being concentrated into relative density is 1.05, obtains medicine juice extractum; (3) preparation of pharmaceutical compositions: ferrous porphyrin extract and medicine juice extractum are mixed, add zinc sulfate and sugar, at room temperature dry, promptly obtain this pharmaceutical composition.
Embodiment 6
The pharmaceutical composition that is used to enrich blood, the component of this pharmaceutical composition is: ferrous porphyrin extract 13.9g, zinc sulfate 0.08g, Fructus Jujubae 0.9g, Fructus Lycii 1.2g, Fructus Crataegi 1.2g and sugared 1.3g.
With reference to Fig. 1, the preparation method of this drug regimen is: the preparation of (1) ferrous porphyrin extract: at first, get the animal blood powder, add water and carry out homogenate, boiled 15 minutes, cooling back with mass percent be 0.5% NaOH to modulate pH value be 7, add the hydrolyzed protein enzymatic solution of 2000 units, mix homogeneously, hydrolysis under 30 ℃ of temperature, adding ethanol to precipitation and do not show red, filter, is 1.15 with solution concentration to relative density, add ethanol once more and remove deproteinize, filter, it is 1.20 that filtrate is concentrated into relative density, obtains hemachrome extract; Then, will contain chlorophyllous biomaterial and dry, use the ethanol lixiviate, extract chlorophyll, at 95 ℃ of concentrated recovered alcohols, regulating pH value with hydrochloric acid is 7, adds ferrous sulfate at 10: 5 according to chlorophyll amount and iron ion amount, under boiled condition, generate iron pheophytin, precipitation is separated out, and excessive ferrous sulfate runs off with supernatant, and flushing is precipitated to the iron-free reactant salt repeatedly, carry out drying, obtain iron chlorophyll extract; Be mixing in 1: 9 with above-mentioned hemachrome extract and iron chlorophyll extract according to mass ratio at last, form the ferrous porphyrin extract; (2) preparation of medicine juice extractum: after Fructus Lycii, Fructus Jujubae and Fructus Crataegi mixing, decoct with water 2 hours, filter, medicinal residues decoct with water 1.5 hours again, and the waste extracting juice merges medicine juice, and being concentrated into relative density is 1.05, obtains medicine juice extractum; (3) preparation of pharmaceutical compositions: ferrous porphyrin extract and medicine juice extractum are mixed, add zinc sulfate and sugar, at room temperature dry, promptly obtain this pharmaceutical composition.
Embodiment 7
Pharmaceutical composition in the foregoing description can be made graininess, capsule shape or tablet shape.The pharmaceutical composition that is used to enrich blood that adopts above-mentioned any embodiment to make can effectively be treated iron deficiency anemia after taking for a long time, strengthens body immunity.
It should be noted last that, above embodiment is only unrestricted in order to technical scheme of the present invention to be described, although the present invention is had been described in detail with reference to preferred embodiment, those of ordinary skill in the art is to be understood that, can make amendment or be equal to replacement technical scheme of the present invention, and not breaking away from the spirit and scope of technical solution of the present invention, it all should be encompassed in the middle of the claim scope of the present invention.

Claims (3)

1. pharmaceutical composition that is used to enrich blood, it is characterized in that the component of making described pharmaceutical composition is: ferrous porphyrin extract 11.5~15.5g, zinc sulfate 0.05~0.09g, Fructus Jujubae 0.7~1.3g, Fructus Lycii 0.8~1.4g, Fructus Crataegi 0.7~1.3g and sugar 1.1~1.5g; The preparation method of said composition is:
(1) preparation of ferrous porphyrin extract:
At first, get the animal blood powder, add water and carry out homogenate, boiled 8~15 minutes, cooling back is that 0.1~1% NaOH modulation pH value is 7~9 with mass percent, the hydrolyzed protein enzymatic solution of adding 2000~5000 units, and mix homogeneously is 30~50 oHydrolysis under the C temperature adds ethanol to precipitation and does not show red, filters, and be 1.05~1.20 with solution concentration to relative density, add ethanol once more and remove deproteinize, to filter, it is 1.05~1.30 that filtrate is concentrated into relative density, obtains hemachrome extract;
Then, will contain chlorophyllous biomaterial and dry, use the ethanol lixiviate, extract chlorophyll, 60~95 oC concentrates recovered alcohol, regulating pH value with hydrochloric acid is 3~7, add ferrous sulfate according to chlorophyll amount and iron ion amount 10:1~10:5, under boiled condition, generate iron pheophytin, precipitation is separated out, and excessive ferrous sulfate runs off with supernatant, and flushing is precipitated to the iron-free reactant salt repeatedly, carry out drying, obtain iron chlorophyll extract;
Be that 1:9~4:6 mixes with above-mentioned hemachrome extract and iron chlorophyll extract according to mass ratio at last, form the ferrous porphyrin extract;
(2) preparation of medicine juice extractum:
After Fructus Lycii, Fructus Jujubae and Fructus Crataegi mixing, decoct with water 1~4 hour, filter, medicinal residues decoct with water 0.5~2 hour again, and the waste extracting juice merges medicine juice, and being concentrated into relative density is 1.05~1.20, obtains medicine juice extractum;
(3) preparation of pharmaceutical compositions:
Ferrous porphyrin extract and medicine juice extractum are mixed, add zinc sulfate and sugar, at room temperature dry, promptly obtain this pharmaceutical composition.
2. the pharmaceutical composition that is used to enrich blood according to claim 1, it is characterized in that the component of making described pharmaceutical composition is: ferrous porphyrin extract 12.8~14.1g, zinc sulfate 0.06~0.08g, Fructus Jujubae 0.8~1.1g, Fructus Lycii 0.9~1.2g, Fructus Crataegi 0.8~1.2g and sugar 1.2~1.4g.
3. the pharmaceutical composition that is used to enrich blood according to claim 1, it is characterized in that the component of making described pharmaceutical composition is: ferrous porphyrin extract 13.2~13.9g, zinc sulfate 0.07~0.078g, Fructus Jujubae 0.9~1.0g, Fructus Lycii 1.0~1.1g, Fructus Crataegi 0.9~1.1g and sugar 1.23~1.3g.
CN2009103060126A 2009-08-25 2009-08-25 Medicine combination for tonifying blood Expired - Fee Related CN101670017B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2009103060126A CN101670017B (en) 2009-08-25 2009-08-25 Medicine combination for tonifying blood

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2009103060126A CN101670017B (en) 2009-08-25 2009-08-25 Medicine combination for tonifying blood

Publications (2)

Publication Number Publication Date
CN101670017A CN101670017A (en) 2010-03-17
CN101670017B true CN101670017B (en) 2011-05-18

Family

ID=42017573

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009103060126A Expired - Fee Related CN101670017B (en) 2009-08-25 2009-08-25 Medicine combination for tonifying blood

Country Status (1)

Country Link
CN (1) CN101670017B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103638529A (en) * 2013-12-16 2014-03-19 红桃开集团股份有限公司 Preparation method of medicament for enriching blood

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1112006A (en) * 1994-09-10 1995-11-22 谭世平 Tonic instant medicine granules for treatment of anaemia, asthenia and deterioration of functions of organs, and its preparing method

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1112006A (en) * 1994-09-10 1995-11-22 谭世平 Tonic instant medicine granules for treatment of anaemia, asthenia and deterioration of functions of organs, and its preparing method

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
湘夷.女性补血 永驻新颜.《中国健康月刊》.2004,(第2期),92-96. *

Also Published As

Publication number Publication date
CN101670017A (en) 2010-03-17

Similar Documents

Publication Publication Date Title
CN103431318B (en) A special diet for female patients with pigmentation
CN107519203A (en) A kind of preparation method of Cornu Cervi cowl zymolyte, Cornu Cervi cowl zymolyte piece
CN103829230A (en) Health product having anti-fatigue effect and preparation method thereof
CN102349651B (en) Health care food with functions of enhancing immunity and easing fatigue and preparation method thereof
CN101199715A (en) Male-protecting kidney capsule and preparing method thereof
CN101199716A (en) Active male capsule and preparing method thereof
CN101670017B (en) Medicine combination for tonifying blood
CN101461533A (en) Technique for preparing peanut shell dietary fiber using chemical extraction method
JP2004057183A (en) Method for producing agaric mushroom extract
CN100389679C (en) A kind of deer bone granule
CN102772651B (en) Chinese medicine composition for the treatment of wind-dryness impairing the lung type cough and preparation method thereof
CN101747222A (en) Aqueous phase synthesis method of glycine chelated oyster calcium and preparation of high-calcium soy sauce
CN103202858A (en) Pig bone nutrient and bone-strengthening and blood-generating oral liquid prepared by same
CN108671221A (en) Gugua polypeptide composition and its application
CN101357141B (en) Water-soluble mixing active pearl calcium and preparation method thereof
CN103445168A (en) Compound trepang particle chewable tablet and preparation method thereof
CN103238711A (en) Food healthcare tea granules for promoting lead excreting
CN107712785A (en) A kind of tune peptide spinach soup of compounding such as cancer peptide and lyophilized spinach and preparation method thereof
CN105077279B (en) The preparation method of an angler stomach cardia peptide and radix glycyrrhizae powder mixture
CN110448641A (en) A kind of health liquor and preparation method thereof for yang-deficiency constitution crowd
CN103333235B (en) Preparation method of selenium-enriched Pinctada martensii protein
CN100379402C (en) Face nursing and beautifying Chinese medicine composition and its prepn
CN103919132A (en) Preparation method of ant powder containing ant polypeptides and chitosan
CN1259363A (en) Complex prescription capsule for strengthening yang and tonifying kidney and prepn. method thereof
CN103271992B (en) Pharmaceutical composition for improving immunity

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20110518

Termination date: 20110825